Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Группа авторов
A, et al. Severe hypertriglyceridemia‐related pancreatitis: characteristics and predictors of recurrence. Pancreas 2019; 48:182–186.
35 35 Preiss D, Tikkanen, MJ, Welsh P. et al. Lipid‐modifying therapies and risk of pancreatitis. JAMA 2012; 308(8):804–811.
36 36 Raphael KL, Wellingham FF. Hereditary pancreatitis: current perspectives. Clin Exp Gastroenterol 2016; 9:197–207.
37 37 Jalaly NY, Moran RA, Fargahi F, et al. An evaluation of factors associated with pathogenic PRSS1, SPINK1, CTFR, and/or CTRC genetic variants in patients with idiopathic pancreatitis. Am J Gastroenterol 2017; 112:1320–1329.
38 38 Hasan A, Moscoso DI, Kastrinos F. The role of genetics in pancreatitis. Gastrointest Endosc Clin North Am 2018; 28:587–603.
39 39 Weiss FU, Hasselbarth N, Párniczky, et al. Common variants in the CLDN2‐MORC4 and PRSS1‐PRSS2 loci confer susceptibility to acute pancreatitis. Pancreatology 2018; 18:477–481.
40 40 Lindkvist B, Appelros S, Manjer J, et al. A prospective cohort study of smoking in acute pancreatitis. Pancreatology 2008; 8(1):63–70.
41 41 Talukdar R, Vege SS. Recent developments in acute pancreatitis. Clin Gastroenterol Hepatol 2009; 7(11 Suppl):S3–S9.
42 42 Tenner S. Drug‐induced acute pancreatitis: does it exist? World J Gastroenterol 2014; 20(44):16529–16534.
43 43 Meczker A, Miko A, Gede N et al. Retrospective matched‐cohort analysis of acute pancreatitis induced by 5‐aminosalicylic acid‐derived drugs. Pancreas 2019; 48:488–495.
44 44 Munigala S, Kanwai F, Xian H, et al. Increased risk of pancreatic adenocarcinoma after acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12:1143–1150.
45 45 Chung S‐D, Chen K‐Y, Xirasagar S, et al. More than 9‐times increased risk for pancreatic cancer among patients with acute pancreatitis in Chinese population. Pancreas 2012; 41:142–146.
46 46 Diaz LI, Li Y, Barkin JS. Natural history of spontaneous rupture of a pancreatic pseudocyst into the peritoneal cavity and its minimal noninvasive management. Pancreas 2019; 48(4):e20–e21.
47 47 Kiriyama S, Gabata T, Takada T, et al. New diagnostic criteria of acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17:24–36.
48 48 Ismail OZ, Bhayana V. Lipase or amylase for the diagnosis of acute pancreatitis? Clin Biochem 2017; 50:1275–1280.
49 49 Working Group IAP/APA Pancreatitis Guidelines. IAP/APA evidence‐based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13(4 Suppl 2):e1–e15.
50 50 Tṻrkvatan A, Erden A, Tṻrkoglu et al. Imaging of acute pancreatitis and its complications. Part 1: Acute pancreatitis. Diagn Interv Imaging 2015; 96:151–163.
51 51 Jang JW, Kim M‐H, Oh D, et al. Factors and outcomes associated with pancreatic duct disruption in patients with acute necrotizing pancreatitis. Pancreatology 2016; 16:958–965.
52 52 Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375:1972–1981.
53 53 Di M‐Y, Liu H, Yang Z‐Yet al. Prediction models of mortality in acute pancreatitis in adults. Ann Intern Med 2016; 165:482–490.
54 54 Wu BU. Prognosis in acute pancreatitis. Can Med Assoc J 2011; 183:673–677.
55 55 Singh V, Wu B, Bollen T, et al. A prospective evaluation of the bedside Index Severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol 2009; 104:966–971.
56 56 Singh VK, Wu BU, Bollen TL et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol 2009; 7:1247–1251.
57 57 Koutroumpakis E, Wu BU, Bakker OJ, et al. Admission hematocrit and rise in blood urea nitrogen at 24 h outperform other laboratory markers in predicting persistent organ failure and pancreatic necrosis in acute pancreatitis: a post hoc analysis of three larger prospective databases. Am J Gastroenterol 2015; 110:1707–1716.
58 58 Forsmark CE, Yadav D. Predicting the prognosis of acute pancreatitis. Ann Intern Med 2016; 165(7):523–524.
59 59 Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis, 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102–111.
60 60 Singh VK, Bollen TL, Bechien U et al. An assessment of the severity of interstitial pancreatitis. Clin Gastroenterol Hepatol 2011; 9:1098–1103.
61 61 Vege SS, DiMagno MJ, Forsmark CE, et al. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute Technical Review. Gastroenterology 2018; 154:1103–1139.
62 62 Sinha A, Vazquez NQ, Faghih M, et al. Early predictors of fluid sequestration in acute pancreatitis. A validation study. Pancreas 2016; 45:306–310.
63 63 De‐Madaria E, Banks PA, Moya‐Hoyo N. Early factors associated with fluid sequestration and outcomes of patients with acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12:997–1002.
64 64 Buxbaum JL, Quezada M, Da B, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol 2017; 112:797–803.
65 65 Warndorf MG, Kurtzman JT, Bartel MJ, et al. Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroentrol Hepatol 2011; 9:705–709.
66 66 Crockett SD, Wani S, Gardner TB. AGA Guidelines on initial management of acute pancreatitis. Gastroenterology 2018; 154:1096–1101.
67 67 Singh VK, Gardner TB, Papachristou GI, et al. An international multicenter study of early intravenous fluid administration and outcomes in acute pancreatitis. United Eur Gastroenterol J 2017; 5(4):491–498.
68 68 Zavyalov T, Khotsyna Y, Tenner S. The role of antibiotics in the management of patients with acute necrotizing pancreatitis. Curr Infect Dis Rep 2010; 12:13–18.
69 69 Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2010;(5):CD002941.
70 70 Adler DG, Chari ST, Dahl TJ, et al. Conservative management of infected necrosis complicating severe acute pancreatitis. Am J Gastroenterol 2003; 98:98–102.
71 71 Runzi M, Niebel W, Goebell H, et al. Severe acute pancreatitis: nonsurgical treatment of infected necroses. Pancreas 2005; 30:195–199.
72 72 Bakker OJ, van Brunschot HC, van Santvoort MG, et al. Early versus on‐demand naso‐enteric tube feeding in acute pancreatitis. N Engl J Med 2014; 371:1983–1993.
73 73 Cote GA. Early enteral feeding does not improve outcomes in patients with predicted severe acute pancreatitis. Gastroenterology 2015; 148:1476–1478.
74 74 Zhao X, Zhu SF, Xue GJ, et al. Early oral refeeding based on hunger in moderate and severe acute pancreatitis: a prospective controlled, randomized clinical trial. Nutrition 2015; 31:171–175.
75 75 Vaughn VM, Shuster D, Rogers MAM, et al. Early versus delayed feeding in patients with acute pancreatitis. A systematic review. Ann Intern Med 2017; 166:883–892.
76 76 Bevan MG, Asrani VM, Bharmal et al. Incidence and predictors of oral feeding intolerance in acute pancreatitis: a systematic review, meta‐analysis and meta regression. Clin Nutr 2017; 36:722–729.
77 77 Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Crit Care 2010; 19:261–268.
78 78 Bakker OJ, van Brunschot S, Farre A, et al. Timing of enteral nutrition in acute pancreatitis: meta‐analysis of individuals using a single‐arm of randomized trials. Pancreatology 2014; 14:340–346.
79 79 Jin M, Zhang H, Lu B, et al. The optimal timing of enteral nutrition and its effect on the prognosis of acute pancreatitis: a propensity score matched cohort study. Pancreatology 2017; 17:651–657.
80 80 Petrov MS, van